16.04.25
Global Health
Its a huge exporter of generic drugs – but are are they safe? And what could Trump’s tariffs mean for the ‘pharmacy of the world’?
10.04.25
It’s an invasive practice that has been tackled by court rulings and government action. So why is it still going on?
04.04.25
Behind the scenes of a major story a year in the making
21.02.25
Country that ‘achieved the impossible’ in reducing deaths to zero now faces closure of key treatment centre
13.02.25
Sub-Saharan Africa has access to just 2.5% of the snake antivenom treatments it needs
5.4 million people are bitten by snakes each year – and of these, 80,000 to 140,000 people die
In sub-Saharan Africa patients face a “Wild West” where treatments for snake bites cost the earth or don’t work
The first snake antivenom was made in the 1890s and the method to make them hasn’t changed much since
05.02.25
By gutting government records, the president is obscuring information about life-and-death issues
03.12.24
Figures close to new president have already been making moves to influence reproductive services around the world
20.11.24
Big Tobacco
Project has sold credits to EasyJet, British American Tobacco and Ernst & Young
05.11.24
Key documents relating to Valerie Huber’s Protego project are being kept away from the public eye
27.09.24
Signatories have agreed to secure clean water in medical facilities and cut antibiotic pollution in the environment
16.09.24
Global Superbugs
A study in The Lancet has forecast that without action 39 million people will die of drug resistant diseases over the next 25 years
08.08.24
In Nigeria and Ethiopia, neonatal sepsis poses a major threat to newborns. And as antibiotic resistance grows, a crisis is mounting
15.07.24
Behind the scenes on a major year-long investigation into Philip Morris
01.07.24
Major new TBIJ investigation uncovers two arrangements in which six-figure sums were paid to intermediaries
Government has long held close connections to Big Tobacco – and the relationship is enshrined in policy
Whistleblower lifts the lid on tactics used by tobacco giant to push its flagship product
Document leaked to TBIJ reveals a corporate vision that stands in marked contrast to public pronouncements
